NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Licata, Anna ^a   Corrao, Salvatore ^a   Petta, Salvatore ^a   Genco, Chiara ^a   Cardillo, Mauro ^a   Calvaruso, Vincenza ^a   Cabibbo, Giuseppe ^a   Massenti, Fatima ^a   Cammà, Calogero ^a   Licata, Giuseppe ^a   Craxì, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILIRUBIN; CREATININE; DIURETIC AGENT;

ADULT; ARTICLE; ASCITES; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CHEMOPROPHYLAXIS; CHILD PUGH SCORE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEART DISEASE; HEART LEFT ATRIAL VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PARACENTESIS; PORTAL HYPERTENSION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

CASE-CONTROL STUDIES; FEMALE; HEART ATRIA; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 84881105207     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068364     Document Type: Article

References (28)

1. Møller S, Henriksen JH, (2008) Cardiovascular complications of cirrhosis. Gut 57(2): 268-78.
2. Møller S, Henriksen JH, (2005) The systemic circulation in cirrhosis. In: Malden: Blackwell Gines P, Arroyo V, Rodes J, Schrier RW, eds. Ascites and renal dysfunction in liver disease. 139-55: 2.
3. Iwakiri Y, Groszmann RJ, (2006) The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43: S121-31.
4. Liu H, Gaskari SA, Lee SS, (2006) Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol 12: 837-42.
5. Møller S, Henriksen JH, (2002) Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 87: 9-15.
6. Møller S, Henriksen JH, (2010) Cirrhotic cardiomyopathy. J Hepatol 53(1): 179-90.
7. Lee SS, Liu H, (2007) Cardiovascular determinants of survival in cirrhosis. Gut 56: 746-48.
8. Wong F, Siu S, Liu P, Blendis LM, (2001) Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis? Clin Sci (Lond) 101: 621-628.
9. De Lemos JA, McGuire DK, Drazner MH, (2003) B-type natiuretic peptide in cardiovascular disease. Lancet 362: 316.
10. Weber M, Hamm C (2006) Role of B-type natriuretic peptide (BNP) and NT-pro BNP in clinical routine. Heart 92(6):843-9. Review.
11. Komeichi H, Moreau R, Cailmail S, Gaudin C, Lebrec D, (1995) Blunted natriuresis and abnormal systemic haemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. J Hepatol 22: 319-25.
12. Goetze JP, Kastrup J, Pedersen F, Rehfeld JF, (2002) Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 48(7): 1035-42.
13. Henriksen JH, Gøtze JP, Fuglsang S Christensen E, Bendtsen F, et al. (2003) Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 52(10): 1511-7.
14. Padillo J, Rioja P, Muñoz-Villanueva MC, Ciria R, Muntane J, et al. (2010) BNP as marker of heart dysfunction in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 22(11): 1331-6.
15. Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Gonçalves F, et al. (2010) B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int 30(7): 1059-66.
16. Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F, (2005) Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 20: 1115-20.
17. American Diabetes Association, (2000) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. American Diabetes Association: Clinical Practice Recommendations 2000 Committee Report. Diabetes Care 23: S4-19.
18. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, et al. (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17(10): 1086-119.
19. Corrao S, Paterna S, Arnone S, Costa R, Amato V, et al. (1995) Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for assessing low or very low ejection fraction values? Cardiology 86(6): 503-7.
20. Scaglione R, Argano C, Duro G, Di Chiara T, Nuzzo D, et al. (2010) The Relationship between the Transforming Growth Factor β1T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects. Int J Hypertens 23: 647147.
21. S. Nagueh CP, Appleton TC, Gillebert, Marino PN, Oh JK, et al. (2009) Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography Journal of the American Society of Echocardiography 22. 2: 107-133.
22. Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, et al. (2010) Cirrhotic cardiomyopathy. J Am Coll Cardiol 56(7): 539-49.
23. Pozzi M. Carugo S, Boari G, Pecci V, de Ceglia S, et al. (1997) Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 26: 1131-7.
24. Coutu P, Bennett CN, Favre EG, Day SM, Metzger JM, (2004) Parvalbumin corrects slowed relaxation in adult cardiac myocytes expressing hypertrophic cardiomyopathy-linked alpha-tropomyosin mutations. Circ Res 94: 1235-41.
25. Bortoluzzi A, Ceolotto G, Gola E, Sticca A, Bova S, et al. (2013) Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms. Hepatology 57(1): 266-76.
26. Mani AR, Ippolito S, Centelles MN, Moore KP, (2012) Nitric oxide-dependent bradycardia in mutant analbuminemic rats. Biochem Pharmacol 15 84(8): 1062-9.
27. Ma Z, Lee SS, Meddings JB (1997) Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy. J Hepatol 26; 904-912.
28. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, et al. (2003) Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 52: 1200-5.